Lexicon Pharmaceuticals (NASDAQ:LXRX – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “strong sell” rating to a “hold” rating in a report issued on Sunday, Wall Street Zen reports. LXRX has been the subject of several other reports. Zacks Research cut Lexicon Pharmaceuticals from a “strong-buy” rating to a […]

Portillo’s (NASDAQ:PTLO – Get Free Report) was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Sunday, Wall Street Zen reports. A number of other equities research analysts also recently weighed in on the company. UBS Group cut their target price on Portillo’s […]

Patterson-UTI Energy (NASDAQ:PTEN – Get Free Report) was upgraded by Wall Street Zen from a “hold” rating to a “buy” rating in a report released on Saturday, Wall Street Zen reports. Other equities research analysts have also issued reports about the stock. UBS Group upped their price objective on shares of Patterson-UTI Energy from $13.00 […]

CB Financial Services (NASDAQ:CBFV – Get Free Report) was upgraded by analysts at Wall Street Zen to a “hold” rating in a research report issued on Saturday, Wall Street Zen reports. A number of other analysts have also recently weighed in on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of CB […]

Pasqal (NASDAQ:PSQL – Get Free Report) was upgraded by investment analysts at Wall Street Zen to a “sell” rating in a research note issued on Saturday, Wall Street Zen reports. PSQL has been the subject of a number of other reports. UBS Group set a $16.00 price objective on shares of Pasqal in a research […]

SKYX Platforms (NASDAQ:SKYX – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a report issued on Saturday, Wall Street Zen reports. Several other brokerages have also recently weighed in on SKYX. Weiss Ratings restated a “sell (e+)” rating on shares of SKYX […]

aTyr Pharma (NASDAQ:ATYR – Get Free Report) was upgraded by Wall Street Zen to a “hold” rating in a research note issued on Saturday, Wall Street Zen reports. Separately, Weiss Ratings cut aTyr Pharma from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, September 16th. One investment analyst has […]